In fact, altered XBP1 expression and RIDD activity has been extensively analyzed in several human cancers with controversial results since both pro-tumorigenic and tumor-suppressor activity of IRE1α have been reported (Blazanin et al., 2017; Bujisic et al., 2017; Logue et al., 2018). The gene discussed is XBP1; the disease is neoplasm.